News

Several presentations at ASCRS 2026 spotlight faster dry eye relief and smarter pre-operative care, showing lifitegrast and new drugs can ease symptoms quickly and improve cataract biometry.

Expanded guidance incorporates advanced diagnostics and reinforces treatment of conditions such as Demodex blepharitis and neuropathic pain, explains Christopher E. Starr, MD, FACS.

The TECNIS Eyhance IOL is part of the TECNIS platform, which Johnson & Johnson said has been used in ophthalmology for more than 25 years.

The survey also examined interest in elective procedures such as LASIK.

The phase 3 study was a randomized, double-masked, placebo-controlled, multicenter trial evaluating subcutaneous teprotumumab administered every 2 weeks for 24 weeks.

Diana Canto-Sims, OD, kicks off her interview series with a conversation with Kevin J. Kovach, MD, on comanagement.

Images showed that Parkinson disease is associated with a thicker photoreceptor nuclear layer and a thinner layer of photoreceptor processes.

The study demonstrates that Corynebacterium mastitidis, a bacterium that resides on the ocular surface, can be genetically modified to secrete the anti-inflammatory cytokine interleukin-10.

AlloSpan Canal is designed to address limitations associated with existing approaches by combining nitinol-guided canaloplasty with biological reinforcement.

Sex hormones play important but distinct roles in regulating the ocular surface and adnexal tissues.

This study sheds light on use of the 0.05% atropine, which has been reported to be effective against myopia progression in some but not all studies.

Elegrobart was generally well tolerated in both dose groups with low rates of hearing impairment.

Corticosteroids remain a cornerstone of postoperative management.

The formulation combines 2 pharmacologic agents: carbachol, a direct-acting cholinergic agonist, and brimonidine tartrate, an α-2 adrenergic receptor agonist.

Eye care providers took on dry eye, pediatric eye care, contact lens wear, and more.

Phase 2 ArMaDa data show statistically significant 31% reduction in geographic atrophy lesion growth with OCU410 at 12 months, with a favorable safety profile supporting phase 3 development.

Strengthen optometry-ophthalmology comanagement with clear referral vs consultation terminology, smart specialist selection, and efficient communication to improve patient outcomes and grow your practice.

An off-the-shelf corneal cell injection targets FECD and bullous keratopathy, aiming to restore vision and ease donor shortages.

Luminopia, formerly cleared by the FDA for amblyopia in children, has begun its foray into IXT with positive data from a preliminary investigation.

China clears first mite-targeting drop for Demodex blepharitis, bringing Xdemvy-style relief and new options beyond lid scrubs and tea tree oil.

Caution is advised by doctors and aviation safety experts.

Michael Raizman, MD, and colleagues evaluated the efficacy and safety of epithelium-on oxygen-enriched corneal CXL in a sub-group analysis of 30 eyes of 22 pediatric patients aged 13 to 17 years.

The study was carried out between July 8 and August 1, 2024, and included 127 eyes from 68 children aged 8–14 years.

QoL areas measured included enjoying relationships/life, overall mood, and time spent thinking of eye pain.

The prospective, multicenter study enrolled 318 patients across 20 US sites.

Erin Rueff, OD, PhD, FAAO, DipAAO, stated that the expanded parameters are set to launch on the lens's 10-year anniversary.